Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.2337/dc18-0338 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Glucagon-like peptide-1 receptor agonists to treat chronic liver disease: real-world evidence or ambiguity?
Gut
April 2024
Gastroenterology and Hepatology, Baylor College of Medicine, Houston, Texas, USA.
GLP-1 Receptor Agonists and Gastrointestinal Adverse Events.
JAMA
March 2024
Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital, Boston, Massachusetts.
Simplifying pharmacotherapy for patients with COPD: a viewpoint.
Eur Respir J
December 2023
Centre for Clinical Epidemiology, Lady Davis Institute-Jewish General Hospital, Montreal, QC, Canada
Regional brain glucose metabolism is differentially affected by ketogenic diet: a human semiquantitative positron emission tomography.
Eur J Nucl Med Mol Imaging
June 2023
APHM, CNRS, Centrale Marseille, Institut Fresnel, AP-HM, La Timone Hospital, CERIMED, Nuclear Medicine Department, Aix Marseille Univ, Marseille, France.
Purpose: Ketogenic diet (KD) is recommended to avoid intense [F]FDG myocardial physiologic uptake in PET imaging. Neuroprotective and anti-seizure effects of KD have been suggested, but their mechanisms remain to be elucidated. This [F]FDG PET study aims to evaluate the effect of KD on glucose brain metabolism.
View Article and Find Full Text PDFRegarding: Webster-Clark M., et al. Alternative analytic and matching approaches for the prevalent new-user design: a simulation study. Pharmacoepidemiol Drug Saf, 31, pp. 796-803; 2022.
Pharmacoepidemiol Drug Saf
December 2022
Centre for Clinical Epidemiology, Lady Davis Institute, Jewish General Hospital, Montreal, Québec, Canada.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!